Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials

Part of paid clinical trials in San Francisco, California.

Sponsor
Power Life Sciences Inc.
Study ID
NCT06174493
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Clinical trials, specifically focused on atopic dermatitis, are crucial in assessing the safety and efficacy of new treatments. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation. The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.

Key Dates

Start date
Jan 31, 2025
Status verified
Feb 2024
Primary completion
Jan 31, 2026
Completion
Jan 31, 2027

Study Design

Enrollment
500 participants (estimated)

Primary Outcome Measure

Number of atopic dermatitis patients who decide to enroll in a clinical research [ Time Frame: 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Power Life SciencesSan FranciscoCalifornia94107
Michael B Gill
https://www.withpower.com/[email protected]
415-900-4227

Find similar trials in San Francisco, CA

By condition
Atopic dermatitis / eczema
By specialty
DermatologyRheumatologyAutoimmune disease
By research site
Power Life Sciences· San Francisco, CA

Related Studies